Search Results
Results found for "Chris de Graaf"
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
GPCR drugmaker Septerna amasses $288M in IPO Surrounded by AI bio giants, tiny startup Nabla Bio makes de
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
Learn how to transform your program from a series of disconnected efforts into a predictable, de-risked
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Seven transmembrane receptors as nature's prototype allosteric protein: de-emphasizing the geography Manchanda Y, ElEid L, Oqua AI, Ramchunder Z, Choi J, Shchepinova MM, et al. Protein Eng Des Sel. 2016;29(12):583-594. 47. Crilly SE, Ko W, Weinberg ZY,Puthenveedu MA.
- 📰 GPCR Weekly News, April 8 to 14, 2024
This week's highlight includes congrats to: Tessa de Vries, Graham Ladds, Antoinette MaassenVanDenBrink
- 📰 GPCR Weekly News, March 27 to April 4, 2023
ended 31 December 2022 Addex Raises $5.0 Million in Equity Financing Testing the limits of SMILES-based de
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
Bénard, G., Ramos, A., Reguero, L., Arrabal, S., Elezgarai, I., Gerrikagoitia, I., Suarez, J., Rodríguez De
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
Cary, B.P., et al., New Insights into the Structure and Function of Class B1 GPCRs.
- Nanobodies: New Dimensions in GPCR Signaling Research
G., Choi, H. J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., Devree, B. T., Rosenbaum, D.
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
.; Van De Veen, W.; Akdis, M.; Ortega-Gutiérrez, S.; López-Rodríguez, M. L.; Akdis, C.
